๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum

โœ Scribed by Kimberly L. Jones; Alaa H. Hegab; Bettina C. Hillman; Keith L. Simpson; Patricia A. Jinkins; Matthew B. Grisham; Michael W. Owens; Etsuro Sato; Richard A. Robbins


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
134 KB
Volume
30
Category
Article
ISSN
8755-6863

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Falsely elevated serum tobramycin concen
โœ Okan Elidemir; Stephanie R. Maciejewski; Christopher M. Oermann ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 24 KB

A recently developed tobramycin preparation for inhalation (TOBIเฎพ, Pathogenesis Corp., Seattle, WA) is widely used in CF patients. It is often used in conjunction with intravenous tobramycin. Renal and ototoxicity associated with the use of tobramycin require that serum drug concentrations be monito

Effects of sputum oscillations and rhDNa
โœ Bonnie Dasgupta; Neil E. Brown; Malcolm King ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 61 KB ๐Ÿ‘ 2 views

Mucolytic treatment with rhDNase is part of the current therapy for cystic fibrosis (CF) lung disease. The Flutterเฎพ valve, a device for enhancing airway mucus clearance, has recently been approved for use in CF patients. Exhalation through the Flutterเฎพ valve leads to oscillations of expiratory airfl